AI has become a critical tool in diagnosing and managing viral infections such as influenza, respiratory syncytial virus (RSV ...

Prasad’s departure may outline the political limits of medical skepticism in the Republican party, at least when it comes to ...

Findings reinforce the need for approaches to minimize the risk of awakening lung DCCs and metastatic disease in cancer survivors who develop respiratory virus infections.

In a study involving mice exposed to COVID-19, researchers found the respiratory infections triggered dormant cancer cells to wake up, setting the stage for new tumors.

Receiving treatment within the first month of life could protect children for at least three years, a study suggests.

Scientists used a mRNA-based vaccine to reliably trigger antibodies that block HIV infection in people and monkeys ...

We may be a step closer to a highly effective mRNA vaccine against HIV, but tests so far reveal that the approach can cause ...

HIV antivirals may be the key to stopping HTLV-1, a deadly virus with no cure. In a decade-long study, researchers ...

Around 10 million people globally live with the life-threatening virus HTLV-1. Yet it remains a poorly understood disease ...

In a recent landmark study, scientists have unveiled how HIV-1 penetrates the cell's nuclear barrier—a discovery that could reshape antiviral strategies. The research, led by Professor Peijun Zhang, ...

Newborns exposed to HIV during pregnancy or birth should receive preventive antiretroviral medication immediately after delivery to reduce the risk of transmission from mother to child.

This study presents a mathematical framework designed to investigate the interactions and progression of HIV-HBV co-infection within a host. The model captures the distinct biological characteristics ...